-
Jul.072021NEWS
HanAll\'s Partner HBM Announces Positive Topline Results from Phase 2 of Batoclimab in MG
HanAll\'s Partner HBM Announces Positive Topline Results from Phase 2 of Batoclimab in MG
-
May.062021NEWS
HanAll Biopharma Reports First Quarter 2021 Financial Results
HanAll Biopharma Reports First Quarter 2021 Financial Results
-
Apr.132021NEWS
HanAll Biopharma Appoints David Hernandez as Vice President of Clinical Development Operations
HanAll Biopharma Appoints David Hernandez as Vice President of Clinical Development Operations
-
Mar.292021NEWS
HanAll Biopharma, Restructured to Seung-kook Park and Seung-won Jeong Joint Representative System, Accelerating Advancement as a Global Biopharmaceutical Company
HanAll Biopharma, Restructured to Seung-kook Park and Seung-won Jeong Joint Representative System, A..
-
Mar.122021NEWS
HanAll Biopharma’s Chinese Partner HBM Initiates the First Dosing of Phase 3 in Dry Eye Disease
HanAll Biopharma’s Chinese Partner HBM Initiates the First Dosing of Phase 3 in Dry Eye Disease
-
Feb.082021NEWS
HanAll Biopharma Completes Meeting with FDA for next Phase 3 Trials in Dye Eye Disease
HanAll Biopharma Completes Meeting with FDA for next Phase 3 Trials in Dye Eye Disease